DigiMed Bayern

DigiMed Bayern for the Medicine of the Future

 

P4 medicine (predictive, preventive, personalized, participatory) is one of the world's most promising developments for improved, holistic and efficient health care. DigiMed Bayern's goal is to guide Bavaria into this medicine of the future with a lighthouse project.

The lighthouse P4-medicine project DigiMed Bayern was launched at the end of 2018 with over 20 million € funding by the Bavarian State Ministry of Health and Care. DigiMed Bayern combines comprehensive datasets of patients diagnosed with atherosclerotic diseases, such as coronary heart disease and stroke, or with genetic risk factors. This dataset will be further enriched with state-of-the-art multi-dimensional molecular characterization (-omics technologies) of associated sample material. For the integrative analysis of the resulting "Big Data", an ethically and legally compliant, highly secure and sustainable IT infrastructure will be fundamentally designed and implemented. Finally, patients and persons at risk will benefit from advancements in disease risk prediction, targeted prevention, diagnosis and treatment.

Superior goals of DigiMed Bayern

1.    Using the example of atherosclerosis, a first analysis of comprehensive data sets in the sense of digital medicine of the future is carried out. All those involved in the health care system in Bavaria should benefit directly: the prediction for coronary heart disease (CHD) and stroke should be made more accurate in the short term and preventive treatment should be improved. In the medium to long term improvements in diagnosis and therapy are pursued. The population-wide identification of familial hypercholesterinemia as an exemplary risk factor for atherosclerosis should be sustainably improved.
2.    The technical, legal and social possibilities and limitations of P4 medicine are recorded, promoted and documented by means of concrete implementation. This includes a proactive multi-directional information exchange with all those involved in health, with a focus on systemic development.
3.    Resulting insights and structures should be expandable in the health system, in research and in the economy and be transferable to other diseases. In particular, an exemplary and transferable integrated digital infrastructure should be created.
4.    Bavaria as a location for P4 medicine should be substantially developed, including international perception and internationally networking.

 

Planned duration:
Q4 2018 to Q4 2023

 

Scientific Directorate:   
German Heart Centre Munich

Managing Directorate:   
BioM Biotech Cluster Development GmbH


Initially involved Institutions   


    More information: Description of the work packages of DigiMed Bayern (pdf).

    DigiMed Bayern Public Seminar

     

    23.4.2019, 5pm
    Advanced digital platforms for projects dealing with sensitive health data

    Leon du Toit
    Section Leader, Research Services
    Services for Sensitive Data, University of Oslo, Center for IT
    Prof. Dr. Thomas Berlage
    Head of Life Science Informatics
    Fraunhofer Institute for Applied Information Technology

     

    1.4.2019, 5pm
    Patient care improvement and clinical performance measurement by patient data profiling and cluster visualization

    Prof. Dr. Martijn A. Spruit
    Scientific Advisor CIRO, Professor in Rehabilitation of Chronic Organ Failure, Maastricht University, The Netherlands
    Professor in Rehabilitation Sciences and Physiotherapy, Hasselt University, Belgium

    13.3.2019, 5pm
    Handling Precision Medicine: Yes We Can! (And What We Can't)

    Olaf Lodbrok, MBA
    Senior Vice President & General Manager, Precision Medicine, Elsevier
    Dr. Klaus Heumann
    CEO, Biomax Informatics 

    25.2.2019, 5pm
    From Biobanking to Precision Medicine: The Estonian Way
    Prof. Dr. Andres Metspalu
    The Estonian Genome Center, Institute of Genomics, University of Tartu, Estonia

    31.1.2019, 5pm
    Catalan open innovation hub on ICT-supported integrated care services for chronic patients
    Prof. Dr. Josep Roca
    Hospital Clinic de Barcelona. IDIBAPS. University of Barcelona

    21.1.2019, 6pm
    Systems BioMedicine - trying to merge basic research with health care data
    Prof. Dr. Reinhard Schneider
    ELIXIR-Luxembourg node
    Bioinformatics Core Facility of the Luxembourg Centre for Systems Biomedicine

    9.1.2019, 5pm
    Systems Medicine - A big data driven disruptive view on current medicine
    Prof. Dr. Jan Baumbach
    Chair of Experimental Bioinformatics, TU Munich



    Dr. Jens Wiehler
    Dr. Jens Wiehler

    Managing Director DigiMed Bayern


    Dr. Ruoyu Sun
    Dr. Ruoyu Sun

    Project Manager DigiMed Bayern


    project funded by: